Aoki Diabetes Research Institute (ADRI) was founded in 1986 by Thomas T. Aoki,
M.D., to further research efforts in the areas of diabetes and metabolism. Located
in Sacramento, CA, ADRI is an independent non-profit organization.

Research

Research conducted by ADRI has included basic science laboratory investigations
and also studies of clinical outcomes. Much of ADRI's research relates to a type
of intravenous insulin therapy called metabolic activation therapy or MAT®treatment. ADRI
has also offered specialized chemistry laboratory testing, diagnostic testing for
osteoporosis, and is often a collaborator in multi-site clinical trials of pharmaceuticals.
ADRI is supported by grants and donations. The fund raising efforts by patients,
families, staff and friends continue to inspire, encourage, and sustain ADRI.

Clinical Treatment

For over twenty years ADRI has also provided MAT® treatments for patients who
are not enrolled in research studies. Patients are referred to ADRI for MAT®treatments
when they have progressive diabetic complications despite intensive therapy. Patients
from all over Northern California and Nevada have benefited from this treatment
program, frequently staying with the program for years.

Many insurance companies, including Medicare, currently refuse to pay for metabolic
activation therapy despite improvements in the patient’s health status while on this
therapy. In many patients, MAT® treatments can save medical costs by reducing
hospitalizations and can reduce employer’s costs due to time lost from work. Generous
donations to ADRI over the years have made it possible for many patients to receive
treatment at ADRI despite their insurance company’s refusal to pay.